European Health Forum Gastein
Annual TOPRA Lecture 2026
Skoll World Forum 2026
World Health Summit 2026
AI in Health Conference with OECD
29th ABRAMGE Congress
The Abramge Congress is one of the most relevant and influential supplementary healthcare events in Latin America. It brings together the sector’s top leaders, experts, and national and international authorities to discuss the present and future of healthcare in Brazil.
With each edition, the Congress consolidates itself as a strategic event for driving major transformations in the sector, addressing innovations, new care models, regulatory policies, and the main economic challenges.
A space dedicated to dialogue, the Abramge Congress is a bridge for connections and real opportunities. Here, you’ll find high-level networking, quality content, and insights to inspire concrete actions and assertive decisions for supplemental healthcare.
Whether you’re looking to stay abreast of regulatory changes, learn about solutions, or stay ahead of the curve in the sector’s evolution, this is the essential event for those who lead, transform, and make supplementary healthcare happen in Brazil.
World Health Summit 2025
European Health Forum Gastein
Harnessing AI for Health and Economic Competitiveness: Translating the EU AI Act into action
Wednesday, 1 October 2025 | 10:30-11:45 | Kursaal
Organised by HealthAI, supported by Roche
The EU AI Act represents a landmark regulatory framework to govern artificial intelligence. It is a horizontal legislation which applies across all industries, including health, where its successful implementation is key for countries to transform Europe’s health systems — driving improved patient outcomes, strengthening public health resilience, and accelerating innovation and economic value. This session will focus on generating strategic insights to translate the Act’s potential into national realities.
The panel, consisting of policymakers, patient groups, payers and innovators, will explore how the health sector, an already highly regulated space, offers a unique opportunity to demonstrate the interplay and potential complementarity between existing medical device and health regulations and the Act. In addition, approaches for implementation and enforcement of the Act across Europe’s health systems will be discussed, with opportunities and challenges highlighted. Finally, a roadmap for scaling responsible AI-driven innovations that improve health outcomes and economic competitiveness will be broadly articulated.